TrialCardiovascular diabetology2022

Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts.

Raffaele Marfella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.